MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$123,214,000
EPS
$1.08
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
0
0
0
0
Research and development
29,497,000
31,454,000
29,347,000
34,068,000
General and administrative
17,425,000
17,057,000
14,684,000
18,351,000
Restructuring
0
-
-68,000
-172,000
Total operating expenses
46,922,000
48,511,000
43,963,000
52,247,000
Loss from operations
-46,922,000
-48,511,000
-43,963,000
-52,247,000
Gain from sale of prv
178,190,000
-
-
-
Interest expense
473,000
473,000
473,000
473,000
Interest and other income, net
347,000
161,000
690,000
709,000
Accretion of discount on investments, net
693,000
1,229,000
1,208,000
1,679,000
Earnings (losses) before income taxes
131,835,000
-
-
-
Provision for income taxes
8,621,000
-
-
-
Net income (loss)
123,214,000
-47,594,000
-42,538,000
-50,332,000
Basic EPS
1.09
-0.42
-0.38
-0.45
Diluted EPS
1.08
-0.42
-0.38
-0.45
Basic Average Shares
112,844,880
112,134,059
111,810,836
111,571,136
Diluted Average Shares
114,513,964
112,134,059
111,810,836
111,571,136
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Gain from sale of prv
$178,190,000
Accretion of discount on
investments, net
$693,000
(-68.78%↓ Y/Y)
Interest and other
income, net
$347,000
(-28.16%↓ Y/Y)
Earnings (losses) before
income taxes
$131,835,000
Loss from operations
-$46,922,000
(34.05%↑ Y/Y)
Interest expense
$473,000
(0.00%↑ Y/Y)
Net income (loss)
$123,214,000
(278.78%↑ Y/Y)
Provision for income taxes
$8,621,000
Total operating
expenses
$46,922,000
(-34.05%↓ Y/Y)
Research and development
$29,497,000
(-30.85%↓ Y/Y)
General and
administrative
$17,425,000
(-30.36%↓ Y/Y)
Buy us a coffee
ROCKET PHARMACEUTICALS, INC. (RCKT)
ROCKET PHARMACEUTICALS, INC. (RCKT)